A drug called alirocumab, given as a 75mg shot every couple of weeks, lowered bad cholesterol by almost half in people at high risk for heart problems over six months — a bit less than another similar drug, evolocumab.

A drug called evolocumab, when given every two weeks, cuts bad cholesterol by more than 60% in people at high risk for heart problems — and that result has shown up consistently in several major studies.

A drug called alirocumab may help prevent serious heart problems and even lower the chance of dying from heart disease in people at high risk — but we’re still not totally sure about the life-extending effects because the data is limited.

If you take certain cholesterol-lowering shots like evolocumab or alirocumab every few weeks, they can cut your 'bad' cholesterol by about 60%, even if you're already on cholesterol pills, have a genetic form of high cholesterol, or can't handle statins.

For people with diabetes who don’t have serious artery disease, adding a drug called evolocumab to their usual cholesterol medicine lowers bad cholesterol a lot — down to 52, compared to 111 without it — after a year.

For people with heart disease who are already taking cholesterol-lowering pills, adding a drug called evolocumab can slash their bad cholesterol by about 60% in less than a year—bringing it down to very low levels.